Patents by Inventor Boan LI

Boan LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Target marker GP73 for detecting steatohepatitis and detection application method
    Patent number: 11067579
    Abstract: A novel serological target marker GP73 used for diagnosing and identifying a simple fatty liver and steatohepatitis in populations with fatty liver and a detection application method thereof. The serological target marker GP73 and the application thereof can replace golden standard liver puncture to identify and diagnose the simple fatty liver and steatohepatitis in populations with fatty liver, reduce the detection pain of a patient, and have an extremely high clinical application value in clinically identifying and diagnosing the simple fatty liver and steatohepatitis in the populations with fatty liver and assisting the treatment of the simple fatty liver and steatohepatitis.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: July 20, 2021
    Assignees: BEIJING DITAN HOSPITAL CAPITAL MEDICAL UNIVERSITY, BEIJING HOTGEN BIOTECH CO., LTD
    Inventors: Hongshan Wei, Boan Li, Changqing Lin, Yong Qiao
  • TARGET MARKER GP73 FOR DETECTING STEATOHEPATITIS AND DETECTION APPLICATION METHOD
    Publication number: 20200217846
    Abstract: A novel serological target marker GP73 used for diagnosing and identifying a simple fatty liver and steatohepatitis in populations with fatty liver and a detection application method thereof. The serological target marker GP73 and the application thereof can replace golden standard liver puncture to identify and diagnose the simple fatty liver and steatohepatitis in populations with fatty liver, reduce the detection pain of a patient, and have an extremely high clinical application value in clinically identifying and diagnosing the simple fatty liver and steatohepatitis in the populations with fatty liver and assisting the treatment of the simple fatty liver and steatohepatitis.
    Type: Application
    Filed: June 19, 2017
    Publication date: July 9, 2020
    Inventors: Hongshan WEI, Boan LI, Changging LIN, Yong QIAO
  • Composition and system for separating and detecting alpha-fetoprotein variant and use thereof
    Patent number: 10329335
    Abstract: Disclosed are a composition and system for separating and detecting an alpha-fetoprotein variant, comprising a separation reagent and a detection reagent; a system for separating and detecting an alpha-fetoprotein variant and a use thereof; and a kit for separating and detecting the alpha-fetoprotein variant. By means of the composition and system for separating and detecting the alpha-fetoprotein variant, and the use thereof, primary liver cancer can be indicated early on, the sensitivity is high, and the method is rapid, simple and automated.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: June 25, 2019
    Assignee: BEIJING HOTGEN BIOTECH CO., LTD.
    Inventors: Haifeng Luo, Boan Li, Changqing Lin
  • COMPOSITION AND SYSTEM FOR SEPARATING AND DETECTING ALPHA-FETOPROTEIN VARIANT AND USE THEREOF
    Publication number: 20180009863
    Abstract: Disclosed are a composition and system for separating and detecting an alpha-fetoprotein variant, comprising a separation reagent and a detection reagent; a system for separating and detecting an alpha-fetoprotein variant and a use thereof; and a kit for separating and detecting the alpha-fetoprotein variant. By means of the composition and system for separating and detecting the alpha-fetoprotein variant, and the use thereof, primary liver cancer can be indicated early on, the sensitivity is high, and the method is rapid, simple and automated.
    Type: Application
    Filed: December 30, 2015
    Publication date: January 11, 2018
    Inventors: Haifeng LUO, Boan LI, Changqing LIN